Animal Antimicrobials and Antibiotics Market Outlook (2023 to 2033)

According to Future Market Insights research, during the projected period, the Global animal antimicrobials and antibiotics market is expected to grow at a CAGR of 4.9%. The market value is projected to increase to US$ 7,878.2 million by 2033.

Demand for animal antimicrobials and antibiotics is expected to rise as a result of the widespread use of various types of meat and milk in dairy products, notably in the western diet, and the rapid spread of similar eating habits worldwide.

Attribute Details
Animal Antimicrobials and Antibiotics Market Size Value in 2023 US$ 4,911.9 million
Animal Antimicrobials and Antibiotics Market Forecast Value in 2033 US$ 7,878.2 million
Global Animal Antimicrobials and Antibiotics Market Growth Rate (2023 to 2033) 4.9%

The market is growing due to factors like the rise in zoonotic illnesses, the demand for animal-derived food products, and the adoption of regulations to curb the spread of animal diseases. Due to rising demand for pet insurance and rising expenditures for veterinary care, this market share for animal antimicrobials and antibiotics is predicted to grow.

During the forecast period, animal antimicrobials and antibiotics market participants can anticipate tremendous development potential due to the untapped emerging markets of China, India, and Brazil, as well as the rise in the overall population of companion animals.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Recent Trends Influencing the Animal Antimicrobials and Antibiotics Market

  • Research and Development

Sales of animal antimicrobials and antibiotics are soaring as a result of the leading companies' new medication innovations and enhanced research and development facilities, which are fueling the demand for effective treatment of animal diseases.

It is anticipated that increasing numbers of people own companion animals and are willing to spend money to ensure their health and welfare. This is likely to support the expansion of the animal health industry, which then fuels the demand for animal antimicrobials and antibiotics.

  • Government Initiatives

The development of early warning systems for the majority of animal diseases by a number of government and non-government groups has fueled the expansion of the global market for animal antibiotics and antimicrobials.

  • Restricting Factor

Strict regulatory requirements and rising use of antibiotic substitutes like feed enzymes and probiotics are some of the reasons partially limiting the growth of the global market for animal antibiotics and antimicrobials.

Human infections that are resistant to antibiotics can lengthen sickness times, increase hospital admissions, and treatment failures that are fatal. Nearly 400,000 people per year die from food-borne illnesses, with children under the age of five accounting for over one-third of these deaths, according to the WHO.

Therefore, veterinarians advise treating animals with less potent antibiotics. These actions could have a big impact on how frequently antibiotics are used worldwide.

FDA Approach: Animal Antimicrobials and Antibiotics Market for Production Purpose

In addition to organizing listening sessions across the nation to hear the concerns of both producers and veterinarians, FDA has been working closely with the American Veterinary Medical Association, other veterinary associations, and groups that represent animal producers.

Based on our outreach, they are convinced that veterinarians and animal producers are aware of their responsibility in ensuring the proper and prudent administration of the animal antimicrobials and antibiotics.

Medically significant animal antimicrobials and antibiotics can no longer be used for production if manufacturers voluntarily adopt these changes; instead, they must be ordered or prescribed by a qualified veterinarian in order to continue treating, controlling, or preventing disease in food animals.

FDA is presently investigating methods for strengthening current data gathering efforts in partnership with other agencies, such as USDA and CDC. FDA expects to seek additional public feedback, as it creates these improvements in animal antimicrobials and antibiotics.

The USA, European, and Japanese regulatory agencies are brought together by the Veterinary International Committee for Harmonization (VICH), which also harmonizes the rules and technical specifications for registering veterinary products.

Nandini Roy Choudhury
Nandini Roy Choudhury

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Comparative View of Adjacent Animal Antimicrobials and Antibiotics Market

Animal Antimicrobials and Antibiotics Market:

Attributes Animal Antimicrobials and Antibiotics Market
CAGR (2023 to 2033) 5%
Market Value (2033) US$ 7,878.2 million
Growth Factor The need for food products made from animals and zoonotic diseases are driving up market expansion.
Opportunity It is projected that the growing number of people who own companion animals will significantly influence the market.
Key Trends Improved research and development facilities are increasing the demand for efficient animal illness treatments.

Companion Animal Drugs Market:

Attributes Companion Animal Drugs Market
CAGR (2023 to 2033) 4.9%
Market Value (2033) US$ 60.92 billion
Growth Factor Demand is high as there is a strong need to safeguard the entire household providing care from any potential health concerns given by animals.
Opportunity The emergence of new technology, particularly in biologics, like canine recombinant vaccines, is anticipated to eventually fuel the demand for veterinary medical specializations.
Key Trends Recent trends include increased pet ownership and knowledge of pet health issues, as well as improvements to healthcare infrastructure, such as better facilities

Companion Animal Specialty Drugs Market:

Attributes Companion Animal Specialty Drugs Market
CAGR (2023 to 2033) 4.2%
Market Value (2033) US$ 56.76 billion
Growth Factor Demand for companion animal specialty pharmaceuticals is anticipated to increase once recombinant DNA vaccinations for dogs are developed.
Opportunity Particularly in the USA and the United Kingdom, baby boomers have been adopting cats and dogs more frequently as pets, creating profitable regional prospects.
Key Trends Social media adoption and initiatives to raise public awareness of animal abuse and pet adoption have had a positive impact on the market.

Researchers have demonstrated that an increase in animal disease rates always corresponds to an increase in human illness rates. Therefore, in order to provide safe food, cattle traders rely heavily on animal antibiotics.

Moreover, the growing demand for meat, milk, and other animal food products is another element influencing the industry. Demand for animal antimicrobials and antibiotics are predicted to be high globally as a result of the extensive use of different types of meat and milk in dairy products, particularly in the western diet, and the rapid adoption of these eating patterns worldwide.

A rise in Antimicrobial resistance (AMR) in humans and animals as a result of increased strain on healthcare systems that are dependent on antibiotics to treat secondary bacterial infections is anticipated to have an influence on the post-COVID future.

Antimicrobial resistance (AMR) is linked to events including disruptions in antibiotic stewardship programmes in healthcare facilities and communities, the over prescription of antibiotics during telehealth consultations, and the ease with which patients can get medications from internet pharmacies. Consumer attitudes about items derived from animals are predicted to be negatively impacted by this.

Regional Outlook

What is the North America Outlook for the Animal Antimicrobials and Antibiotics Market?

Geographically, North America dominates the market for animal antibiotics and antimicrobials, owing to the region's high prevalence of animal disease outbreaks, excessive consumption of livestock products, prevalence of pet ownership, and elevated awareness of animal disease outbreaks.

The leading market participants in North America are also making significant financial investments in the creation of medicines to treat animal ailments, prompting the demand for animal antimicrobials and antibiotics.

How Asia Pacific is Performing in the Animal Antimicrobials and Antibiotics Market?

On a global scale, the market for animal antibiotics and antimicrobials is expanding at the quickest rate in Asia Pacific. The region's rapid expansion is related to the rise in the number of animals, the demand for animal antibiotics, and the prevalence of animal diseases.

Additionally, the market for animal antibiotics and antimicrobials in the Asia Pacific region is expanding as a result of rising disposable income, a rise in the number of people owning pets as companions, and a rise in government involvement in the fight against the spread of animal diseases in developing nations such as India and China.

Asian nations are predicted to experience the highest growth in the demand for livestock products like beef, milk, mutton, pork, and poultry products, according to a 2018 FAO (Food and Agriculture Organization of the United Nations) survey on mapping the supply and demand for food sourced from animals.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Competitive Landscape

An important development in the market for animal antibiotics and antimicrobials is the strategic collaboration. In order to conduct research and produce cutting-edge animal antibiotics and antimicrobials, companies are forming strategic alliances with key industry players.

Recent Developments in the Market

  • Trianni Inc. (USA) and Zoetis (USA) have decided to work together on developing transgenic monoclonal antibody platforms for the discovery of innovative veterinary medications. This collaboration began in July 2020. The FDA approved Zoetis' purchase of Marboquin (USA).
  • Elanco (USA) and AgBiome worked together to provide nutritional health solutions for pigs in 2019.
  • By balancing its food animal and companion animal divisions, Elanco Animal Health (USA) announced in 2019 that it purchases Bayer's Animal Health Business, boosting its own companion animal business and portfolio mix.
  • In 2019, Sanofi (France) purchased the Animal Health division of Boehringer Ingelheim (Germany) (Merial), and Boehringer Ingelheim (Germany) (CHC) was bought by Sanofi. After acquiring Merial, BI became the second-largest animal health firm in the world.

Animal Antimicrobials and Antibiotics Market Report Scope

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis USD million for Value and Units for Volume
Key Regions Covered
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • MEA
Key Countries Covered
  • USA
  • Canada
  • Mexico
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Brazil
  • Argentina
  • South Africa
  • UAE
Key Segments Covered
  • Product Type
  • Animal Type
  • Mode of Delivery
  • Region
Key Companies Profiled
  • Bayer AG
  • BoehringerIngelheim GmbH
  • CevaSanteAnimale
  • Dechra Pharmaceuticals PLC
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Sanofi
  • Vetoquinol S.A.
  • Virbac
  • Zoetis, Inc.
  • Elanco Animal Health
  • Phibro Animal Health
  • Virbac
  • Kyoritsu Seiyaku (Japan)
  • Tianjin Ringpu
  • HIPRA
  • Zydus Animal Health
  • Inovet
Report Coverage Market Forecast, Company Share Analysis, Competitive Landscape, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing Available upon Request

Animal Antimicrobials and Antibiotics Market by Category

By Product Type:

  • Tetracyclines
  • Penicillins
  • Sulfonamides
  • Macrolides
  • Aminoglycosides
  • Lincosamides
  • Fluoroquinolones
  • Cephalosporins
  • Other Antimicrobials and Antibiotics

By Animal Type:

  • Companion Animals
  • Food Producing Animals

By Mode of Delivery:

  • Premixes
  • Oral Powder
  • Oral Solution
  • Injection

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

How Big is the Animal Antimicrobials and Antibiotics Market?

The market is valued at US$ 4,911.9 million in 2023.

Which are the Top 3 Companies Leading in the Market?

The leading companies in the market are Zoetis, Merck, and Elanco.

Which Industry is the Key Consumer of the Market?

The food industry is the primary consumer of the market.

How Big will the Animal Antimicrobials and Antibiotics Market by 2033?

The market is estimated to reach US$ 7,878.2 million by 2033.

What is the Expected Growth Rate for Animal Antimicrobials and Antibiotics Market?

The market is expected to record a CAGR of 4.9% by 2033.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (MT) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (MT) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By Product Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By Product Type, 2023 to 2033

        5.3.1. Tetracyclines

        5.3.2. Penicillins

        5.3.3. Sulfonamides

        5.3.4. Macrolides

        5.3.5. Aminoglycosides

        5.3.6. Lincosamides

        5.3.7. Fluoroquinolones

        5.3.8. Cephalosporins

        5.3.9. Others

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Animal Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By Animal Type, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By Animal Type, 2023 to 2033

        6.3.1. Companion Animals

        6.3.2. Food Producing Animals

    6.4. Y-o-Y Growth Trend Analysis By Animal Type, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Animal Type, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Mode of Delivery

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By Mode of Delivery, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By Mode of Delivery, 2023 to 2033

        7.3.1. Premixes

        7.3.2. Oral Powder

        7.3.3. Oral Solution

        7.3.4. Injection

    7.4. Y-o-Y Growth Trend Analysis By Mode of Delivery, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By Mode of Delivery, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. The USA

            9.2.1.2. Canada

        9.2.2. By Product Type

        9.2.3. By Animal Type

        9.2.4. By Mode of Delivery

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By Animal Type

        9.3.4. By Mode of Delivery

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product Type

        10.2.3. By Animal Type

        10.2.4. By Mode of Delivery

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Animal Type

        10.3.4. By Mode of Delivery

    10.4. Key Takeaways

11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. United Kingdom

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Western Europe

        11.2.2. By Product Type

        11.2.3. By Animal Type

        11.2.4. By Mode of Delivery

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Animal Type

        11.3.4. By Mode of Delivery

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Product Type

        12.2.3. By Animal Type

        12.2.4. By Mode of Delivery

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Animal Type

        12.3.4. By Mode of Delivery

    12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Product Type

        13.2.3. By Animal Type

        13.2.4. By Mode of Delivery

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Animal Type

        13.3.4. By Mode of Delivery

    13.4. Key Takeaways

14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Product Type

        14.2.3. By Animal Type

        14.2.4. By Mode of Delivery

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By Animal Type

        14.3.4. By Mode of Delivery

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Product Type

        15.2.3. By Animal Type

        15.2.4. By Mode of Delivery

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product Type

        15.3.3. By Animal Type

        15.3.4. By Mode of Delivery

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Product Type

            16.1.2.2. By Animal Type

            16.1.2.3. By Mode of Delivery

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Product Type

            16.2.2.2. By Animal Type

            16.2.2.3. By Mode of Delivery

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Product Type

            16.3.2.2. By Animal Type

            16.3.2.3. By Mode of Delivery

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Product Type

            16.4.2.2. By Animal Type

            16.4.2.3. By Mode of Delivery

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Product Type

            16.5.2.2. By Animal Type

            16.5.2.3. By Mode of Delivery

    16.6. United Kingdom

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Product Type

            16.6.2.2. By Animal Type

            16.6.2.3. By Mode of Delivery

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Product Type

            16.7.2.2. By Animal Type

            16.7.2.3. By Mode of Delivery

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Product Type

            16.8.2.2. By Animal Type

            16.8.2.3. By Mode of Delivery

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Product Type

            16.9.2.2. By Animal Type

            16.9.2.3. By Mode of Delivery

    16.10. Poland

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Product Type

            16.10.2.2. By Animal Type

            16.10.2.3. By Mode of Delivery

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Product Type

            16.11.2.2. By Animal Type

            16.11.2.3. By Mode of Delivery

    16.12. Czech Republic

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Product Type

            16.12.2.2. By Animal Type

            16.12.2.3. By Mode of Delivery

    16.13. Romania

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Product Type

            16.13.2.2. By Animal Type

            16.13.2.3. By Mode of Delivery

    16.14. India

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Product Type

            16.14.2.2. By Animal Type

            16.14.2.3. By Mode of Delivery

    16.15. Bangladesh

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Product Type

            16.15.2.2. By Animal Type

            16.15.2.3. By Mode of Delivery

    16.16. Australia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Product Type

            16.16.2.2. By Animal Type

            16.16.2.3. By Mode of Delivery

    16.17. New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Product Type

            16.17.2.2. By Animal Type

            16.17.2.3. By Mode of Delivery

    16.18. China

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Product Type

            16.18.2.2. By Animal Type

            16.18.2.3. By Mode of Delivery

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Product Type

            16.19.2.2. By Animal Type

            16.19.2.3. By Mode of Delivery

    16.20. South Korea

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Product Type

            16.20.2.2. By Animal Type

            16.20.2.3. By Mode of Delivery

    16.21. GCC Countries

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Product Type

            16.21.2.2. By Animal Type

            16.21.2.3. By Mode of Delivery

    16.22. South Africa

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2022

            16.22.2.1. By Product Type

            16.22.2.2. By Animal Type

            16.22.2.3. By Mode of Delivery

    16.23. Israel

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2022

            16.23.2.1. By Product Type

            16.23.2.2. By Animal Type

            16.23.2.3. By Mode of Delivery

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product Type

        17.3.3. By Animal Type

        17.3.4. By Mode of Delivery

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Bayer AG

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

                18.1.1.5.2. Product Strategy

                18.1.1.5.3. Channel Strategy

        18.1.2. BoehringerIngelheim GmbH

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

                18.1.2.5.2. Product Strategy

                18.1.2.5.3. Channel Strategy

        18.1.3. CevaSanteAnimale

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

                18.1.3.5.2. Product Strategy

                18.1.3.5.3. Channel Strategy

        18.1.4. Dechra Pharmaceuticals PLC

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

                18.1.4.5.2. Product Strategy

                18.1.4.5.3. Channel Strategy

        18.1.5. Eli Lilly and Company

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

                18.1.5.5.2. Product Strategy

                18.1.5.5.3. Channel Strategy

        18.1.6. Merck & Co., Inc.

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

                18.1.6.5.2. Product Strategy

                18.1.6.5.3. Channel Strategy

        18.1.7. Sanofi

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

                18.1.7.5.2. Product Strategy

                18.1.7.5.3. Channel Strategy

        18.1.8. Vetoquinol S.A.

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

                18.1.8.5.2. Product Strategy

                18.1.8.5.3. Channel Strategy

        18.1.9. Virbac

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

                18.1.9.5.2. Product Strategy

                18.1.9.5.3. Channel Strategy

        18.1.10. Zoetis, Inc.

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

                18.1.10.5.2. Product Strategy

                18.1.10.5.3. Channel Strategy

        18.1.11. Elanco Animal Health

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

                18.1.11.5.2. Product Strategy

                18.1.11.5.3. Channel Strategy

        18.1.12. Phibro Animal Health

            18.1.12.1. Overview

            18.1.12.2. Product Portfolio

            18.1.12.3. Profitability by Market Segments

            18.1.12.4. Sales Footprint

            18.1.12.5. Strategy Overview

                18.1.12.5.1. Marketing Strategy

                18.1.12.5.2. Product Strategy

                18.1.12.5.3. Channel Strategy

        18.1.13. Virbac

            18.1.13.1. Overview

            18.1.13.2. Product Portfolio

            18.1.13.3. Profitability by Market Segments

            18.1.13.4. Sales Footprint

            18.1.13.5. Strategy Overview

                18.1.13.5.1. Marketing Strategy

                18.1.13.5.2. Product Strategy

                18.1.13.5.3. Channel Strategy

        18.1.14. Kyoritsu Seiyaku (Japan)

            18.1.14.1. Overview

            18.1.14.2. Product Portfolio

            18.1.14.3. Profitability by Market Segments

            18.1.14.4. Sales Footprint

            18.1.14.5. Strategy Overview

                18.1.14.5.1. Marketing Strategy

                18.1.14.5.2. Product Strategy

                18.1.14.5.3. Channel Strategy

        18.1.15. Tianjin Ringpu

            18.1.15.1. Overview

            18.1.15.2. Product Portfolio

            18.1.15.3. Profitability by Market Segments

            18.1.15.4. Sales Footprint

            18.1.15.5. Strategy Overview

                18.1.15.5.1. Marketing Strategy

                18.1.15.5.2. Product Strategy

                18.1.15.5.3. Channel Strategy

        18.1.16. HIPRA

            18.1.16.1. Overview

            18.1.16.2. Product Portfolio

            18.1.16.3. Profitability by Market Segments

            18.1.16.4. Sales Footprint

            18.1.16.5. Strategy Overview

                18.1.16.5.1. Marketing Strategy

                18.1.16.5.2. Product Strategy

                18.1.16.5.3. Channel Strategy

        18.1.17. Zydus Animal Health

            18.1.17.1. Overview

            18.1.17.2. Product Portfolio

            18.1.17.3. Profitability by Market Segments

            18.1.17.4. Sales Footprint

            18.1.17.5. Strategy Overview

                18.1.17.5.1. Marketing Strategy

                18.1.17.5.2. Product Strategy

                18.1.17.5.3. Channel Strategy

        18.1.18. Inovet

            18.1.18.1. Overview

            18.1.18.2. Product Portfolio

            18.1.18.3. Profitability by Market Segments

            18.1.18.4. Sales Footprint

            18.1.18.5. Strategy Overview

                18.1.18.5.1. Marketing Strategy

                18.1.18.5.2. Product Strategy

                18.1.18.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Food and Beverage

Pet Food Microalgae Market

July 2021

REP-GB-13362

June 2023

333 pages

Food and Beverage

Pet Food Ingredients Market

February 2022

REP-GB-14311

February 2023

350 pages

Explore Food and Beverage Insights

View Reports
Future Market Insights

Animal Antimicrobials and Antibiotics Market